FDA Proposes Exemptions for Marketing Applications of Certain Antibiotic Drugs

Summary

The FDA is proposing regulations to exempt marketing applications for certain antibiotic drug products from marketing exclusivity and patent provisions, aiming to align with the Food and Drug Administration Modernization Act of 1997, which went into effect on November 21, 1997.